Genital Neoplasms, Female
"Genital Neoplasms, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
| Descriptor ID |
D005833
|
| MeSH Number(s) |
C04.588.945.418 C13.351.937.418
|
| Concept/Terms |
Genital Neoplasms, Female- Genital Neoplasms, Female
- Neoplasms, Female Genital
- Gynecologic Neoplasms
- Neoplasms, Gynecologic
- Gynecologic Neoplasm
- Neoplasm, Gynecologic
- Female Genital Neoplasms
- Female Genital Neoplasm
- Genital Neoplasm, Female
- Neoplasm, Female Genital
|
Below are MeSH descriptors whose meaning is more general than "Genital Neoplasms, Female".
Below are MeSH descriptors whose meaning is more specific than "Genital Neoplasms, Female".
This graph shows the total number of publications written about "Genital Neoplasms, Female" by people in this website by year, and whether "Genital Neoplasms, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 4 | 0 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 4 | 0 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genital Neoplasms, Female" by people in Profiles.
-
Chelmow D, Brooks R, Cavens A, Huber-Keener K, Scott DM, Sheth SS, Whetstone S, Worly B, Burke W. Executive Summary of the Uterine Cancer Evidence Review Conference. Obstet Gynecol. 2022 Apr 01; 139(4):626-643.
-
Holtz DO, Shahin MS. Changes to outpatient evaluation and management coding: 2021 will be a better year. Gynecol Oncol. 2021 06; 161(3):871-875.
-
Moawad GN, Wu C, Klebanoff JS, Urbina P, Alkatout I. Pelvic Neuroanatomy: An Overview of Commonly Encountered Pelvic Nerves in Gynecologic Surgery. J Minim Invasive Gynecol. 2021 02; 28(2):178.
-
Brant JM, Hirschman KB, Keckler SL, Dudley WN, Stricker C. Patient and Provider Use of Electronic Care Plans Generated From Patient-Reported Outcomes. Oncol Nurs Forum. 2019 11 01; 46(6):715-726.
-
Ahmed A, Deng W, Tew W, Bender D, Mannel RS, Littell RD, DeNittis AS, Edelson M, Morgan M, Carlson J, Darus CJ, Fleury AC, Modesitt S, Olawaiye A, Evans A, Fleming GF. Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study. Gynecol Oncol. 2018 08; 150(2):300-305.
-
Bruce SF, Carr DN, Burton ER, Sorosky JI, Shahin MS, Naglak MC, Edelson MI. Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomy. Gynecol Oncol. 2018 06; 149(3):560-564.
-
Graul A, Latif N, Zhang X, Dean LT, Morgan M, Giuntoli R, Burger R, Kim S, Ko E. Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program. Int J Gynecol Cancer. 2017 03; 27(3):581-587.
-
Uppal S, Shahin MS, Rathbun JA, Goff BA. Since surgery isn't getting any easier, why is reimbursement going down? An update from the SGO taskforce on coding and reimbursement. Gynecol Oncol. 2017 Feb; 144(2):235-237.
-
Baucom RB, Ousley J, Beveridge GB, Phillips SE, Pierce RA, Holzman MD, Sharp KW, Nealon WH, Poulose BK. Cancer?Survivorship: Defining the Incidence of Incisional Hernia After Resection for Intra-Abdominal Malignancy. Ann Surg Oncol. 2016 12; 23(Suppl 5):764-771.
-
Goff BA, Shahin MS, Powell MA, Dowdy SC. SGO Health Policy and Socioeconomic Committee: Current and Future Efforts of the Coding and Reimbursement Taskforce and the Policy, Quality and Outcomes Taskforce. Gynecol Oncol. 2016 11; 143(2):229-230.